Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D Trials

Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):186-188. doi: 10.4103/ijem.ijem_459_21. Epub 2022 Jun 6.

Arpandev Bhattacharyya^{1

2

3}, Indranil Bhattacharya⁴, Vaishali Deshmukh⁵, Viswanathan Mohan⁶, Erik Spaepen⁷

¹ Department of Endocrinology and Diabetes, Manipal Hospital, Bengaluru, Karnataka, India.
² JJM Medical College, Rajiv Gandhi University, Davanagere, Karnataka, India.
³ Shivajoyti Clinic, Bengaluru, Karnataka, India.
⁴ Eli Lilly and Company, Haryana, India.
⁵ Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India.
⁶ Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialties Centre, Chennai, Tamil Nadu, India.
⁷ HaaPACS GmbH, Schriesheim, Germany.

No abstract available